Illumina Inc (ILMN) Stock Price
ILMNStock
$215.59+117.39%52W
Market Cap$32.55B
P/E33.71x
PEG Ratio3.19
Div yield—
Beta1.46
ILMN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)63.49%
Price vs S&P 500 (4W)7.25%
PEG Ratio3.19
VGM Score51.75
P/E Ratio (Annual)33.71x
ILMN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.23 | $1.31 | +6.82%(+$0.08) | |
| Q1 2026 | $1.05 | $1.15 | +9.03%(+$0.10) | |
| Q4 2025 | $1.23 | $1.35 | +9.69%(+$0.12) | |
| Q3 2025 | $1.17 | $1.34 | +14.74%(+$0.17) | |
| Q2 2025 | $1.01 | $1.19 | +17.66%(+$0.18) |
ILMN Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
3.68
3.75
3.71
3.71
Industry Peers — Lab Analytical Instruments(26)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ILMNIllumina Inc | D | D | A | $215.59 |
| AAgilent Technologies Inc. | D | C | B | $153.84 |
| WATWaters Corp | D | C | B | $414.69 |
| MTDMettler-Toledo International | D | C | B | $1398.58 |
| RVTYRevvity, Inc. | C | D | A | $128.80 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | $387.70 |
| AVTRAvantor, Inc. | B | F | A | $14.58 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | $365.08 |
| BRKRBruker Corporation | D | D | B | $57.08 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | $61.54 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | — | B | $30.71 |
About Illumina Inc
Illumina is a leading provider of genetic analysis tools and services for life science and clinical applications. The company derives over 90% of revenue from sequencing instruments, consumables, and related services, offering both high-throughput whole genome sequencing and targeted solutions for viral and cancer detection. Illumina also operates a microarray business (9% of 2024 revenue) serving consumer genomics and agricultural markets with more cost-effective genetic screening options.